CCMG
HAE icon

Clark Capital Management Group’s Haemonetics HAE Stock Holding History

Clark Capital Management Group’s Portfolio HAE Stock Details HAE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-7,024
Closed -$229K – 335
2014
Q1 		$229K Sell
7,024
-257
-4% -$9.82K 0.02% 299
2013
Q4 		$307K Sell
7,281
-209
-3% -$8.6K 0.03% 266
2013
Q3 		$299K Sell
7,490
-192
-2% -$8.05K 0.02% 275
2013
Q2 		$318K Buy
+7,682
New +$311K 0.03% 252

Other funds holding HAE

Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Barrow, Hanley, Mewhinney & Strauss
Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $30.5B AUM 29.95% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
WHG
Westwood Holdings Group Dallas, Texas $13.7B AUM 21.48% 1-Year Est. Return
VBA
Van Berkom & Associates Montreal, Quebec, Canada $3.08B AUM 12.07% 1-Year Est. Return
PP
Prudential plc London, England, United Kingdom $17.1B AUM 15.7% 1-Year Est. Return

Clark Capital Management Group's HAE Position: Q2 2014 in Review

Clark Capital Management Group sold out of Haemonetics (HAE) in Q2 2014, closing a stake of 7,024 shares — an estimated $229K sold.

Clark Capital Management Group first reported a position in HAE in Q2 2013 and held it in 4 quarters. The position peaked at $318K in Q2 2013. 175 funds tracked by Wall St. Rank hold HAE as of Q2 2014.

  • Clark Capital Management Group reported no remaining Haemonetics position as of Q2 2014 after selling out during the quarter.
  • Clark Capital Management Group sold 7,024 Haemonetics shares in Q2 2014, an estimated $229K.
  • Clark Capital Management Group first reported a position in Haemonetics in Q2 2013 and held it in 4 quarters.
  • Clark Capital Management Group's Haemonetics position peaked at $318K in Q2 2013.
  • 175 funds tracked by Wall St. Rank held Haemonetics as of Q2 2014.

Based on Clark Capital Management Group's 13F filing for Q2 2014, filed 4 Aug 2014.